F-star Biotechnology Ltd-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014085)
◆英語タイトル:F-star Biotechnology Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014085
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mAb2 bispecific monoclonal antibodies; fcab, a new binding region within an antibody; and others. F-star develops drugs intended for the treatment of immune-oncology, breast and gastric cancer indications. The company also offers discovery of antibodies which are selected for their potential to transform the treatment of cancer. It operates in the UK and Austria. F-star is headquartered in Cambridge, the UK.

F-star Biotechnology Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
F-Star Alpha Raises US$13 Million In Series A Financing 10
f-star Secures US$21.7 Million In Financing Round 12
Partnerships 14
F-star Biotech Enters into Partnership with Merck 14
Denali Therapeutics Enters into Research Agreement with F-star Biotech 15
F-star Enters into Agreement with University of Natural Resources and Life Sciences 16
f-star Biotechnologische Enters Into Co-Development Agreement With Merck Serono 17
Licensing Agreements 18
F-star Biotech Enters into Licensing Agreement with Genedata 18
F-star Bio Enters into Licensing agreement with AbbVie 19
F-star Beta Enters into Licensing Agreement with F-star Biotech 20
F-star Alpha Enters into Licensing Agreement with F-star Biotech 21
F-star Biotechnology Ltd – Key Competitors 22
F-star Biotechnology Ltd – Key Employees 23
F-star Biotechnology Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Other Significant Developments 25
Mar 18, 2016: F-star Business Update 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 2
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
F-star Biotechnology Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
F-Star Alpha Raises US$13 Million In Series A Financing 10
f-star Secures US$21.7 Million In Financing Round 12
F-star Biotech Enters into Partnership with Merck 14
Denali Therapeutics Enters into Research Agreement with F-star Biotech 15
F-star Enters into Agreement with University of Natural Resources and Life Sciences 16
f-star Biotechnologische Enters Into Co-Development Agreement With Merck Serono 17
F-star Biotech Enters into Licensing Agreement with Genedata 18
F-star Bio Enters into Licensing agreement with AbbVie 19
F-star Beta Enters into Licensing Agreement with F-star Biotech 20
F-star Alpha Enters into Licensing Agreement with F-star Biotech 21
F-star Biotechnology Ltd, Key Competitors 22
F-star Biotechnology Ltd, Key Employees 23
F-star Biotechnology Ltd, Subsidiaries 24

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ F-star Biotechnology Ltd-製薬・医療分野:企業M&A・提携分析(F-star Biotechnology Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆